Skip to main content

Nonprofit · EIN 82-5445706

SARAS CURE

Also known as SARASCURE

Tax-exempt · CHARLESTON, SC 29412

Financials

$100K$105K2022$70K$97K2023$92K$105K2024
Revenue Expenses · by fiscal year end
Financials of SARAS CURE by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990-EZ$91,784$104,700-$12,916$51,801–$51,801
December 31, 2023990-EZ$70,362$96,662-$26,300$64,774$57$64,717
December 31, 2022990-EZ$99,906$105,129-$5,223$91,017–$91,017
Financial details: 990-EZ for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$34,473
Investment income
$3
Net income from fundraising events
$57,308

Expenses

Compensation of officers, directors and key employees
$0
Professional fees and payments to contractors
$89,562
Printing, publications and postage
$1,470
Other expenses
$13,668
Program services (functional)
$109,487

Balance sheet and other

Total assets, start of year
$64,774
Total assets, end of year
$51,801
Total liabilities, end of year
–
Net assets, end of year
$51,801
Cash, savings and investments
$51,801
Gross receipts
$96,569

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990-EZ for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
ANN LOPEZMARKETING DI8$0
LENNIE WOODSEXECUTIVE DI40$0
JILL NEALADMINISTRATI25$0
LISA FAULKNERPATIENT ADVO8$0
KELLY ARGRAVES PHDSCIENTIFIC D8$0
JENAVIEVE MALLORYSOCIAL MEDIA4.5$0
DENNY WOODSBOARD MEMBER0$0
NANETTE DETURKBOARD MEMBER0$0
DRU WILLIAMSBOARD MEMBER0$0
DAWN JUDDTREASURER0$0
JENAE HELLERBOARD MEMBER0$0
BRUCE NEWBYBOARD MEMBER0$0
EVAN BARNESBOARD MEMBER0$0
990-EZ for the year ended December 31, 2023: 9 people
NameTitleHours / weekCompensation
LENNIE WOODSEXECUTIVE DI40$32,000
DENNY WOODSBOARD MEMBER1$0
KELLY ARGRAVES PHDSCIENTIFIC D1$0
NANETTE DETURKBOARD MEMBER1$0
DRU WILLIAMSBOARD MEMBER1$0
DAWN JUDDTREASURER1$0
JENAE HELLERBOARD MEMBER1$0
BRUCE NEWBYBOARD MEMBER1$0
EVAN BARNESBOARD MEMBER1$0
990-EZ for the year ended December 31, 2022: 9 people
NameTitleHours / weekCompensation
LENNIE WOODSEXECUTIVE DI0$0
KELLY ARGRAVES PHDSCIENTIFIC D0$0
JENAE HELLERBOARD MEMBER0$0
DRU WILLIAMSBOARD MEMBER0$0
DAWN JUDDTREASURER0$0
DENNY WOODSBOARD MEMBER0$0
BRUCE NEWBYBOARD MEMBER0$0
NANETTE DETURKBOARD MEMBER0$0
EVAN BARNESBOARD MEMBER0$0

Address and contacts

Address (IRS master file)
783 STILES DR, CHARLESTON, SC 29412-5071
In care of
% LENNIE WOODS
Signed the 990-EZ
DAWN JUDD, TREASURER
Phone
(843) 864-6760
Return prepared by
HINSKE & CLAREY LLC

Mission

THE CLEAR CELL SARCOMA FOUNDATION IS DEDICATED TO MAKING CLEAR CELL SARCOMA SURVIVABLE THROUGH EDUCATION AND SCIENTIFIC RESEARCH. WE STRIVE TO PROVIDE A VOICE AND PLATFORM FOR ALL PATIENTS AND CAREGIVERS IMPACTED BY THIS RARE CANCER, EMPOWERING THEM TO ENACT CHANGE AND WORK TOWARDS A CURE.

990-EZ for the year ended December 31, 2024

Program accomplishments

  • SUMMARY OF ACTIVITIES JANUARY- OUR EXECUTIVE DIRECTOR PARTICIPATED IN A GLOBAL WEBINAR HOSTED BY THE SARCOMA FOUNDATION OF AMERICA TO PRESENT A PRIVATE/PUBLIC PARTNERSHIP CALLED CURE DRUG REPURPOSING COLLABORATORY (CDRC), WITH THE INITIATIVE TO FIND EXISTING DRUGS FOR RARE SARCOMA.: CO-HOSTED OUR LARGEST ANNUAL FUNDRAISER IN CHARLESTON SC. CONTINUED TO COLLABORATE WITH THE CLINICAL/RESEARCH COMMUNITY THROUGH MONTHLY MEETINGS WITH SARC, AND THE CCS TISSUE COLLECTION DOD GRANT COMMUNITY OF STAKEHOLDERS. FEBRUARY & MARCH TEAMED UP WITH XCURES TO CREATE A PARTNERSHIP CONTRACT FOR THE PURPOSE OF COLLECTING ELECTRONIC HEALTH RECORDS ON CCS PATIENTS, AN OUTGROWTH OF THE CDRC PROJECT. THESE REAL WORLD RESULTS WERE PRESENTED AT THE ANNUAL SARCOMA CONFERENCE TO THE SARCOMA COMMUNITY. PLANS FOR EXPANSION INTO 2025. APRIL - INAUGURAL MEETING WITH DR. KEVIN JONES SURGICAL ONCOLOGIST TO PLAN A FIRST EVER CCS SYMPOSIUM IN CHARLESTON SC. SEPTEMBER. THIS MEETING IS FOR THE PURPOSE OF COLLECTING REAL WORLD EXPERIENCES (RWE) FROM CCS PATIENTS THROUGH THE XCURES PLATFORM AND PUBLISHING THE DATA AS A CONSENSUS OF THE NATURAL HISTORY OF CCS. MAY & JUNE CDRC MOVES FORWARD THROUGH OUR OWN FUNDED XCURES PROJECT. PATIENT FAMILIES HELD FUNDRAISERS FOR CCSF INCLUDING THE SOCIETY OF HOPE FUNDRAISER AND THE BOB COSTELLO CCS GOLF TOURNAMENT FUNDRAISER TO SUPPORT THE EHR DATA PROJECT. JULY & AUGUST- SARCOMA AWARENESS MONTH INITIATIVES WERE SENT TO EDUCATE THE COMMUNITY THROUGH OUR NEWSLETTER AND SOCIAL MEDIA TO GET THE WORD OUT ABOUT CCS. CONTINUED DATA COLLECTION/ANALYSIS AND PREPARATION FOR THE UPCOMING INAUGURAL SYMPOSIUM. SEPTEMBER - HELD THE FIRST ANNUAL INTERNATIONAL CCS PATIENT CLINICIAN PARTNERED CCS COLLABORATIVE SYMPOSIUM. PATIENTS MET AND SHARED STORIES IN PERSON AND BY ZOOM. THE MEETING WAS HELD VIRTUALLY FOR OUR GLOBAL COMMUNITY TO ATTEND AS WELL. TWO NEW INITIATIVES AROUND RADIATION THERAPY AND PATIENT DATA WERE BORN AND WILL BE PROGRAMS FOR THE 2025 RESEARCH AT THE CCSF. OCTOBER - WE HELD A CCSF RESEARCH TEAM RETREAT TO ANALYZE EHR DATA SUBMISSION AND PUBLISH A RETROSPECTIVE STUDY ABSTRACT FOR CONNECTIVE TISSUE ONCOLOGY SOCIETY (CTOS) PRESENTATION IN NOVEMBER. WE MET DAILY FOR COLLABORATIVE AND SOMETIMES DIFFICULT WORK ANALYZING THE DATA AND FORMING IT INTO CHARTS THAT WILL DRIVE CLINICAL DECISION MAKING BASED ON RWE TO HELP IMPROVE TREATMENT OUTCOMES. THIS RETREAT WAS WITH PATIENT COMMUNITY INVOLVEMENT AND IS CORE TO OUR MISSION. NOVEMBER - OUR CCS RESEARCH TEAM TRAVELED TO SAN DIEGO TO PRESENT FIRST OF ITS KIND CCS ELECTRONIC HEALTH RECORD DATA (EHR).. MET WITH MD ANDERSON CLINICIANS TO DISCUSS CCS CARE, MET WITH SARC AND CLINICIANS FROM MSK AND ROYAL MARSDEN REGARDING A 2025 TRIAL FOR CCS. WE WERE ABLE TO GIVE SEVERAL TALKS TO CLINICIANS AND RESEARCHERS AT THE POSTER PRESENTATION SESSION. WE HAD SMALL CARD PRINTS TO HAND OUT TO THE ONCOLOGISTS THROUGHOUT THE ANNUAL CONFERENCE. OUR RESEARCH WAS VERY WELL RECEIVED AND HAS LED TO FURTHER DISCUSSIONS AND PARTNERSHIP OPPORTUNITIES. DECEMBER - GIVING TUESDAY AND FUNDRAISER PROJECT TO RAISE FUNDS FOR THE PURCHASE OF 2 NEW MOUSE MODELS NEEDED FOR THE JONES LAB RESEARCH OFF PROJECT. WE SUCCESSFULLY RAISED THE FUNDS NEEDED, DR JONES WAS ABLE TO NEGOTIATE A DISCOUNT FOR US AND WE DIDNT HAVE TO PAY ANY OVERHEAD COSTS.
    Expenses $109,487

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990-EZ on file
2023December 31, 2023May 15, 2024990-EZ on file

IRS record

EIN
82-5445706
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2018
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H30)
Assets (IRS master file)
$51,801
Income (IRS master file)
$96,569

Filing history

FormYear endedRevenueExpensesAssetsReturn
990-EZDecember 2024$91,784$104,700$51,801IRS
990-EZDecember 2023$70,362$96,662$64,774XML
990-EZDecember 2022$99,906$105,129$91,017XML
990-EZDecember 2021–––IRS
990-EZDecember 2020–––IRS
990-EZDecember 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 82-5445706).

Questions about SARAS CURE

What is the EIN of SARAS CURE?
The employer identification number (EIN) of SARAS CURE is 82-5445706.
Is SARAS CURE tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2018.
Are donations to SARAS CURE tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does SARAS CURE file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of SARAS CURE due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did SARAS CURE last file with the IRS?
The latest return in the IRS public files is the 990-EZ for the year ended December 2024.
Who are the officers and directors of SARAS CURE?
The 990-EZ for the year ended December 31, 2024 lists 13 people; 0 received compensation from the organization.
How much revenue does SARAS CURE have?
On its 990-EZ for the year ended December 31, 2024 it reported revenue of $91,784, expenses of $104,700 and total assets of $51,801 at year end.

Other nonprofits in CHARLESTON

All nonprofits in CHARLESTON · South Carolina · Medical research